| Financial Year |
March 31 2023 |
| Monetary Funds |
3,265,944,703.15 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
360,406,872.84 |
| Accounts Receivable |
1,257,305,426.13 |
| Advances to Suppliers |
9,417,950.73 |
| Other Receivables |
1,095,366.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,055,042,138.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,201,398.00 |
| Other Current Assets |
4,271,435.84 |
| Total Current Assets |
6,064,695,291.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
741,045,826.14 |
| Under-construction Projects |
255,719,086.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,820,714.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,270,967.64 |
| Deferred Income Tax Assets |
28,275,741.98 |
| Other Non-Current Assets |
224,648,035.97 |
| Sub-Total of Non-Current Assets |
1,311,780,372.92 |
| Total Assets |
7,376,475,664.34 |
| Short-Term Loans |
79,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
600,668,971.26 |
| Accounts Payable |
566,504,686.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
50,775.94 |
| Taxes Payable |
107,897,347.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
80,826,548.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
100,225,153.63 |
| Sub-Total of Current Liabilities |
1,537,699,119.81 |
| Long-term Loans |
4,759,080.00 |
| Bonds Payable |
822,070,677.41 |
| Long-Term Accounts Payable |
197,602.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,283,841.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
914,072,745.49 |
| Total Liabilities |
2,451,771,865.30 |
| Paid-In Capital(Or Share Stock) |
549,293,176.00 |
| Capital Surplus |
2,470,796,094.35 |
| Surplus Reserve |
173,769,181.40 |
| LESS:Treasury Stock |
80,665,600.00 |
| Undistributed Profits |
1,653,574,525.63 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,924,703,799.04 |
| Owner's Equity（Stockholder's Equity） |
4,924,703,799.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,376,475,664.34 |
